Sophrosyne Technologies Unveils Biomedical Sensor Chipset for Wearables

Bengaluru-based Sophrosyne Technologies Unveils Indigenous Biomedical Sensor Chipset for Wearable Health Monitoring

Bengaluru-based Sophrosyne Technologies Unveils Indigenous Biomedical Sensor Chipset for Wearable Health Monitoring

The chipset is designed to integrate high-precision biomedical sensing capabilities into compact, energy-efficient wearable devices intended to support health-monitoring functions.

Sophrosyne Technologies, a Karnataka-based deeptech semiconductor startup, has unveiled its indigenous biomedical sensor chipset designed for wearable health monitoring applications.

The chipset is designed to enable high-precision biomedical sensing capabilities in compact, energy-efficient wearable devices intended to support health-monitoring functions.

It forms part of the startup’s broader portfolio of System-on-Chip (SoC) solutions and AI-powered healthcare applications for digital health monitoring and diagnostic technologies.

As part of its development, the startup has recently completed post-silicon validation of the first version of the chipset.

During validation, the system reportedly demonstrated vital-sign acquisition capabilities and captured its first live electrocardiogram (ECG) signal using the fabricated silicon.

The development follows the completion of the chip design tape-out in late April 2026, after which the company received the fabricated silicon and began initial validation.

The startup has received support from the Ministry of Electronics and Information Technology (MeitY), the DLI Technical Committee, C-DAC team, and Bluehill VC during its development journey.

Following the validation, the startup plans to develop a commercial-ready version of the chipset.

The startup further seeks to complete the next chip tape-out and initiate proof-of-concept (PoC) engagements with domestic and international wearable device manufacturers within the next 10 months.

Founded in Bengaluru in 2022 by Manish Srivastava and Jatin Gupta, Sophrosyne Technologies is developing high-precision, ultra-low-power System-on-Chip (SoC) solutions and AI-powered healthcare and wellness applications.

By combining semiconductor innovation, AI, and edge computing, the startup aims to advance digital health monitoring and diagnostic technologies through accessible, high-impact solutions.

In November last year, the startup raised $2 million in a seed funding round led by Bluehill. The funding was intended to expand its engineering team, accelerate research and development, advance the transition from prototype silicon to commercial-grade products, and support early customer deployments in India and international markets.

Stay tuned for more such updates on Digital Health News

Follow us

More Articles By This Author


Show All

Welcome back.

Pick up where you left off on Digital Health News.

Sign in to DHN

For existing DHN and DHN Plus members.

or
Continue with Google
New to DHN?